Search

Your search keyword '"Zielonka, D"' showing total 74 results

Search Constraints

Start Over You searched for: Author "Zielonka, D" Remove constraint Author: "Zielonka, D"
74 results on '"Zielonka, D"'

Search Results

1. Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial

3. Identification of symbol digit modality test score extremes in Huntington's disease

4. An altered nucleotide metabolism as a novel mechanism leading to Huntington disease related cardiomyopathy

5. An altered metabolism of nucleotides leads to huntington’s disease related cardiomyopathy

6. A frequency of concomitant disorders in presymptomatic huntington’s disease patients

7. Suicidal ideation in a European Huntington's disease population

11. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

12. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

13. NMDA receptor gene variations as modifiers in Huntington disease: a replication study

14. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY

15. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

16. A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease

17. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

18. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

19. NMDA receptor gene variations as modifiers in Huntington disease

35. The influence of gender on phenotype and disease progression in patients with Huntington's disease

36. Sex contribution to average age at onset of Huntington's disease depends on the number of (CAG) n repeats.

38. Structural Abnormalities of the Optic Nerve and Retina in Huntington's Disease Pre-Clinical and Clinical Settings.

39. Is deep brain stimulation effective in Huntington's Disease? - a systematic literature review.

40. Huntington's Disease Progression and Caregiver Burden.

41. Melatonin secretion in migraine patients: the current state of knowledge.

43. Prevalence of Non-psychiatric Comorbidities in Pre-symptomatic and Symptomatic Huntington's Disease Gene Carriers in Poland.

44. A study in a Polish ataxia cohort indicates genetic heterogeneity and points to MTCL1 as a novel candidate gene.

46. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease.

47. Circadian rhythms of melatonin and cortisol in manifest Huntington's disease and in acute cortical ischemic stroke.

48. An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington's disease related cardiomyopathy.

49. Transcriptional activity of TGFβ1 and its receptors genes in thyroid gland.

50. Update on Huntington's disease: advances in care and emerging therapeutic options.

Catalog

Books, media, physical & digital resources